[DOT 2022] From In Vitro to In Vivo: Assay Panels for the Discovery of New Analgesic Drugs

[DOT 2022] From In Vitro to In Vivo: Assay Panels for the Discovery of New Analgesic Drugs
Version:
21381

File Name/Number:
DOT

Year:
2022

 

Chronic or acute pain is a common reason for people to seek medical care. However, analgesics such as opioids have reduced efficacy due to tolerance or serious side effects such as addiction, leading to abuse and overdose. These drawbacks promote the identification of novel molecular targets and the development of alternative pain therapeutics. Our lab is working on solutions by developing assay panels to effectively discover new analgesics.